The fund’s LPs include the European Investment Fund (EIF) and CDP Venture Capital Sgr.
The fresh 55 North fund received backing from Novo Holdings, EIFO, Vsquared Ventures, Cambium Capital, and strategic support from key industry partners.
The new fund saw support from banks, development finance institutions, pension funds, insurance companies, and family offices.
The Series A extension round was led by Biocodex, with participation from Crescent Ventures, UI Investissement, and Forepont Capital Partners.
The pre-seed round came from Empirical Ventures, Coca-Cola Europacific Partners (CCEP), First Imagine! Ventures, The Conduit EIS Impact Fund, and Almanac Ventures.
The funding round was led by 1confirmation, with support from Collider Ventures, F‑Prime Capital, DCG, Coinbase Ventures, Node Capital, and Arrington Capital.